The European Chronic Disease Alliance (ECDA), the European Public Health Alliance (EPHA) and the NCD Alliance publish a new joint paper “Towards an EU-Strategic Framework for the prevention of Non-communicable Diseases” concluding that a new EU-level strategic framework to prevent non-communicabl…
BioMed Alliance Members have produced a cartoon highlighting the importance of high-quality and unbiased continuing medical education for medical professionals. Medical professionals participate in continuing education to keep their knowledge up to date and to be able to provide the best standard…
The General Assembly of the European Association for the Study of the Liver (EASL) has elected new members to its Governing Board, various committees and a new Editor-In-Chief for its Journal of Hepatology. 12 April 2019 – Vienna, Austria The European Association for the Study of the Liver (EASL)…
New research, presented at the International Liver Congress™, warns that high levels of non-alcoholic fatty liver disease among young people is signalling a public health crisis. Excerpt from The Guardian Study finds substantial numbers of young people at risk of liver cancer, diabetes and heart …
The latest journal from EASL, JHEP Reports is fully open access.Our goal is to become an essential channel for innovation in hepatology by publishing outstanding basic, translational and clinical studies.
It is estimated that 2 billion people are infected with hepatitis B virus (HBV) globally, with 686,000 people dying from complications of the disease each year.
Hepatic encephalopathy (HE) is a frequent complication in patients with chronic liver disease. HE is a complication of cirrhosis that is associated with psychomotor slowing and an increased risk of accidents at home, at work, or while driving a car. Dr Formentin and colleagues aimed to evaluate t…
Before the advent of antiretroviral drugs, the prognosis for patients with AIDS was extremely poor. However, new antiretroviral treatments have revolutionised care for patients with HIV/AIDS, making lifelong viral suppression possible and improving life expectancy to near normal in patients treat…
Liver cancer is a leading cause of cancer death, with hepatocellular carcinoma (HCC) accounting for 85–90% of all primary liver cancers. In a recent issue of Journal of Hepatology, Dr Baumeister et al. showed that higher total physical activity was associated with a reduced risk of HCC, an effect…
DIGESTIVE WELLNESS 14 December 2018 170,000 people in Europe die from liver failure every year. The cirrhosis death toll could be cut from 2020, thanks to advanced dialysis technology being trialled in the UK and Europe now. Many people with liver disease do not see it coming until it’s too late….
